Identification of Hazardous Medicinal Products (HMPs)
In the healthcare sector, 12.7 million workers across the EU are potentially exposed to Hazardous Medicinal Products (HMPs). While these drugs are vital in the treatment of different diseases such as cancers, psoriasis, etc., they can also pose health risks to those exposed to them at work like nurses, pharmacists, cleaners, etc.
The ETUI has identified 121 HMPs commonly used in the healthcare sector which can cause cancer or reproductive disorders in professionals exposed to them on a daily basis. Click here for more information about the report.
This webinar will dig into the report and how to use it.
Date: 12 October 11:00-12:00 CET
Working language: English
Registration is free of charge
Welcome and introduction
Claes-Mikael Ståhl, Deputy general secretary, ETUC (tbc)
The ETUI list of Hazardous Medicinal Products (HMPs)
Ian Lindsley, Secretary of the European Biosafety Network
Q&A with the audience
moderated by Marian Schaapman, Head of the Working conditions, health and safety unit at the ETUI
Tony Musu, senior researcher in the health and safety and working conditions of the ETUI